Phipps MS, Cronin CA. Management of acute ischemic stroke. BMJ. 2020;368:l6983. https://doi.org/10.1136/bmj.l6983.
Wang YJ, Li ZX, Gu HQ, Zhai Y, Jiang Y, Zhao XQ, et al. China Stroke statistics 2019: a Report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and non-communicable Disease Control and Prevention. Stroke Vasc Neurol. 2020;5(3):211–39. https://doi.org/10.1136/svn-2020-000457. Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations.
Article PubMed PubMed Central Google Scholar
Wang YJ, Li ZX, Gu HQ, Zhai Y, Zhou Q, Jiang Y, et al. China Stroke statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and non-communicable Disease Control and Prevention. Stroke Vasc Neurol. 2022;7(5):415–50. https://doi.org/10.1136/svn-2021-001374. Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations.
Article PubMed PubMed Central Google Scholar
Ma Q, Li R, Wang L, Yin P, Yang Y, Global Burden of Disease Study 2019. Temporal trend and attributable risk factors of Stroke burden in China, 1990–2019: an analysis for the. The Lancet Public Health. 2021;6(12):e897–e906. https://doi.org/10.1016/S2468-2667(21)00228-0.
Article PubMed PubMed Central Google Scholar
Xu J, Zhang X, Jin A, Pan Y, Li Z, Meng X, et al. Trends and Risk factors Associated with Stroke recurrence in China, 2007–2018. JAMA Netw Open. 2022;5(6):e2216341. https://doi.org/10.1001/jamanetworkopen.2022.16341.
Article PubMed PubMed Central Google Scholar
Chen Y, Wright N, Guo Y, Turnbull I, Kartsonaki C, Yang L, et al. Mortality and recurrent vascular events after first incident Stroke: a 9-year community-based study of 0·5 million Chinese adults. The Lancet Global Health. 2020;8(4):e580–90. https://doi.org/10.1016/s2214-109x(20)30069-3.
Article PubMed PubMed Central Google Scholar
Wang Y, Xu J, Zhao X, Wang D, Wang C, Liu L, et al. Association of Hypertension with Stroke recurrence depends on ischemic Stroke subtype. Stroke. 2013;44(5):1232–7. https://doi.org/10.1161/STROKEAHA.111.000302.
Emerging Risk Factors Collaboration, Angelantonio ED, Sarwar N, Perry P, Kaptoge S, Ray KK, et al. Major lipids, apolipoproteins, and risk of vascular disease. J Vasc Surg. 2009;18(302):1993–2000. https://doi.org/10.1001/jama.2009.1619.
Park SY, Gautier JF, Chon S. Assessment of insulin secretion and insulin resistance in human. Diabetes & Metabolism Journal. 2021;45(5):641–54. https://doi.org/10.4093/dmj.2021.0220.
Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021; 119(2021):154766. https://doi.org/10.1016/j.metabol.2021.154766.
Deng XL, Liu Z, Wang C, Li Y, Cai Z. Insulin resistance in ischemic Stroke. Metab Brain Dis. 2017;32(5):1323–34. https://doi.org/10.1007/s11011-017-0050-0.
Ago T, Matsuo R, Hata J, Wakisaka Y, Kuroda J, Kitazono T, et al. Insulin resistance and clinical outcomes after acute ischemic Stroke. Neurology. 2018;90(17):e1470–7. https://doi.org/10.1212/WNL.0000000000005358.
Pan Y, Jing J, Chen W, Zheng H, Jia Q, Mi D, et al. Post-glucose load measures of insulin resistance and prognosis of nondiabetic patients with ischemic Stroke. J Am Heart Assoc. 2017;6(1):e004990. https://doi.org/10.1161/JAHA.116.004990.
Article PubMed PubMed Central Google Scholar
Chouchani ET, Kajimura S. Metabolic adaptation and maladaptation in adipose tissue. Nat Metab. 2019;1(2):189–200. https://doi.org/10.1038/s42255-018-0021-8.
Article PubMed PubMed Central Google Scholar
Zhang K, Pan H, Wang L, Yang H, Zhu H, Gong F. Adipose tissue insulin resistance is closely associated with metabolic syndrome in Northern Chinese populations. Diabetes Metab Syndr Obes: Targets Ther. 2021;14:1117–28. https://doi.org/10.2147/dmso.s291350.
Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, et al. Adipose tissue dysfunction as determinant of obesity-Associated Metabolic Complications. Int J Mol Sci. 2019;20(9):2358. https://doi.org/10.3390/ijms20092358.
Article PubMed PubMed Central Google Scholar
Jiang J, Cai X, Pan Y, Du X, Zhu H, Yang X, et al. Relationship of obesity to adipose tissue insulin resistance. BMJ Open Diabetes Res Care. 2020;8(1):e000741. https://doi.org/10.1136/bmjdrc-2019-000741.
Article PubMed PubMed Central Google Scholar
Jorge-Galarza E, Posadas-Romero C, Torres-Tamayo M, Medina-Urrutia AX, Rodas-Diaz MA, Posadas-Sanchez R et al. Insulin resistance in adipose tissue but not in liver is associated with aortic valve calcification. Disease markers. 2016;2016:9085474. https://doi.org/10.1155/2016/9085474.
Wang Y, Jing J, Meng X, Pan Y, Wang Y, Zhao X, et al. The third China National Stroke Registry (CNSR-III) for patients with acute ischaemic Stroke or transient ischaemic Attack: design, rationale and baseline patient characteristics. Stroke Vasc Neurol. 2019;4(3):158–64. https://doi.org/10.1136/svn-2019-000242.
Article PubMed PubMed Central Google Scholar
Listed N. Stroke–1989. Recommendations on Stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular disorders. Stroke. 1989;20(10):1407–31. https://doi.org/10.1161/01.str.20.10.1407.
Jr HPA, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic Stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41. https://doi.org/10.1161/01.str.24.1.35.
Elm Ev, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, andenbroucke JP, et al. Strengthening the reporting of observational studies in epidemiology (StroBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806–8. https://doi.org/10.1136/bmj.39335.541782.AD.
van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in Stroke patients. Stroke. 1988;19(5):604–7. https://doi.org/10.1161/01.str.19.5.604.
Wilson JT, Hareendran A, Grant M, Baird T, Schulz UG, Muir KW, et al. Improving the assessment of outcomes in Stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke. 2002;33(9):2243–6. https://doi.org/10.1161/01.str.0000027437.22450.bd.
Sondergaard E, De Espinosa AE, Morgan-Bathke M, Jensen MD. How to measure adipose tissue insulin sensitivity. J Clin Endocrinol Metab. 2017;102(4):1193–9. https://doi.org/10.1210/jc.2017-00047.
Article PubMed PubMed Central Google Scholar
Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res. 2013;22(3):278–95. https://doi.org/10.1177/0962280210395740.
Zhou MS, Schulman IH, Zeng Q. Link between the renin-angiotensin system and insulin resistance: implications for Cardiovascular Disease. Vasc Med. 2012;17(5):330–41. https://doi.org/10.1177/1358863X12450094.
Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM. Insulin resistance and risk for Stroke. Neurology. 2002;59(6):809–15. https://doi.org/10.1212/wnl.59.6.809.
Jing J, Pan Y, Zhao X, Zheng H, Jia Q, Mi D, et al. Insulin Resistance and prognosis of nondiabetic patients with ischemic Stroke: the ACROSS-China Study (abnormal glucose regulation in patients with Acute Stroke across China). Stroke. 2017;48(4):887–93. https://doi.org/10.1161/STROKEAHA.116.015613.
Nigro J, Osman N, Dart AM, Little PJ. Insulin resistance and Atherosclerosis. Endocr Rev. 2006;27(3):242–59. https://doi.org/10.1210/er.2005-0007.
Cusi K. The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 Diabetes. Curr Diab Rep. 2010;10(4):306–15. https://doi.org/10.1007/s11892-010-0122-6.
Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic Disease. N Engl J Med. 2014;371(12):1131–41. https://doi.org/10.1056/NEJMra1011035.
Mu L, Li R, Lai Y, Zhao Y, Qiao J. Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome. J Endocrinol Invest. 2019;42(5):541–8. https://doi.org/10.1007/s40618-018-0949-2.
Semnani-Azad Z, Connelly PW, Bazinet RP, Retnakaran R, Jenkins DJA, Harris SB, et al. Adipose tissue insulin resistance is longitudinally Associated with adipose tissue dysfunction, circulating lipids, and Dysglycemia: the PROMISE cohort. Diabetes Care. 2021;44(7):1682–91. https://doi.org/10.2337/dc20-1918.
Maida CD, Norrito RL, Daidone M, Tuttolomondo A, Pinto A. Neuroinflammatory mechanisms in ischemic Stroke: focus on Cardioembolic Stroke, background, and therapeutic approaches. Int J Mol Sci. 2020;21(18):6454. https://doi.org/10.3390/ijms21186454.
Article PubMed PubMed Central Google Scholar
Liu H, Zhou X, Liu J, Huang W, Zhao N, Wang H. Rationale and design of the application value of Beijing Vascular Health Stratification (BVHS): predictive value of combined assessment of vascular structure and function for cardiovascular events in general Chinese population. BMC Cardiovasc Disord. 2021;21(1):498. https://doi.org/10.1186/s12872-021-02289-8.
Article PubMed PubMed Central Google Scholar
Aminian A, Zajichek A, Arterburn DE, Wolski KE, Brethauer SA, Schauer PR, et al. Association of metabolic Surgery with major adverse Cardiovascular outcomes in patients with type 2 Diabetes and obesity. JAMA. 2019;322(13):1271. https://doi.org/10.1001/jama.2019.14231.
Article PubMed PubMed Central Google Scholar
Li S, Yin C, Zhao W, Zhu H, Xu D, Xu Q, et al. Homeostasis model assessment of insulin resistance in relation to the poor functional o
Comments (0)